Company / Current Assets
MADRIGAL PHARMACEUTICALS, INC. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$1.2B
FY2025
5-year range
$271.7M / $1.2B
FY2021-FY2025
Trend
+20.6%
vs FY2024
Sector context
#42 of 213
Health Care
What the data says
MADRIGAL PHARMACEUTICALS, INC.'s current assets of $1.2B is higher than 80% of companies in the Health Care sector (FY2025). Current Assets has increased for 4 consecutive years, from $272M in FY2021 to $1.2B in FY2025.
Based on SEC 10-K filings.
$1.2B in FY2025 with a 5-year CAGR of +34.3%. Top quartile in the Health Care sector.
Improved from $637M to $1.2B over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +51.1%
- 5-Year CAGR
- +34.3%
- 10-Year CAGR
- -
Sector benchmark
-50.6% below sector average
Key checks
Key Insights
- MADRIGAL PHARMACEUTICALS, INC.'s current assets has grown for 4 consecutive years.
- 5-year CAGR of +34.3%, indicating consistent growth.
- In FY2025, current assets increased 20.6% year-over-year.
- Ranks #42 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.2B | +20.6% |
| FY2024 | $1.0B | +62.1% |
| FY2023 | $637.3M | +76.4% |
| FY2022 | $361.4M | +33.0% |
| FY2021 | $271.7M | -4.7% |
| FY2020 | $285.2M | -35.2% |
| FY2019 | $440.2M | -9.3% |
| FY2018 | $485.2M | +152.7% |
| FY2017 | $192.0M | +366.0% |
| FY2016 | $41.2M | -58.5% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026